Global Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027

Growth Outlook

• The 2027 portion of the Global Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 14667 Mn in 2026 and is projected to reach USD 15940 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• By 2027, Anti-Infectives is the largest of the 4 groups tracked here, at 5. 19B USD, 33% of the combined total.
• What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
• By 2027, Anti-Infectives alone is expected to reach USD 5190 Mn, with Others at USD 4040 Mn.

Market Dynamics

By 2027, Anti-Infectives is the largest of the 4 groups tracked here, at 5.19B USD, 33% of the combined total.

Second place: Others, 4.04B USD, trailing Anti-Infectives by 22%.

Anti-Infectives grows to 5.19B USD by 2027, from 2.74B USD in 2018 — 89% up.

Others: 2.03B USD to 4.04B USD, 99% higher by 2027.

Antibiotics climbs from 2.06B USD (2018) to 3.84B USD (2027), a 87% gain.

Anti-Inflammatories: 1.37B USD in 2018 to 2.87B USD by 2027, up 110%.

By rate of change, not size, Anti-Inflammatories is the standout — 110% growth, faster than the rest of the group.

Across the full group, the combined total moves from 8.20B USD in 2018 to 15.94B USD in 2027 — a 94% change.

Who Leads, And By How Much

There are 4 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.

Size and growth rate are two different questions here — a series can be small in absolute terms and still be growing the fastest of the group. Check both before drawing a conclusion.

Use this chart to size the Global Companion Animal Healthcare market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.

Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.